Boston biotech Atalanta raises $97M to bring CNS drugs into clinic
Jan 28, 2025 · Atalanta Therapeutics is building on the growing attention around RNA interference (RNAi)-based medicines with a fresh round of venture capital and plans to enter the clinic. The …
OFF
Boston Biotech Atalanta Raises $97M To Bring CNS Drugs Into Clinic
3 weeks from now
Jan 28, 2025 · Atalanta Therapeutics is building on the growing attention around RNA interference (RNAi)-based medicines with a fresh round of venture capital and plans to enter the clinic. The …
bizjournals.com
OFF
Atalanta Therapeutics Closes Oversubscribed $97 Million Series B ...
3 weeks from now
BOSTON, January 28, 2025 – Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the …
atalantatx.com
OFF
Atalanta Banks $97M To Send RNAi Drugs Into The Brain
3 weeks from now
Jan 28, 2025 · Atalanta Therapeutics, a Boston biotechnology company making medicines for the brain from RNA molecules, has raised $97 million to bring its first two drug candidates into …
biopharmadive.com
OFF
RNAi Biotech Atalanta Unveils $97M To Reach The Clinic In Two …
3 weeks from now
Jan 28, 2025 · The structure of Atalanta Therapeutics’ RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntington’s disease and a …
medcitynews.com
OFF
Atalanta Therapeutics Raises $97M In Series B Financing To …
3 weeks from now
Jan 29, 2025 · Atalanta Therapeutics Raises $97M in Series B Financing to Advance RNAi Therapies for CNS Diseases Jan 29, 2025 ... Boston-based Atalanta said it will use the …
precisionmedicineonline.com
OFF
Sanofi- And Novartis-backed Atalanta Loads Crossbow With $97M
3 weeks from now
Jan 28, 2025 · Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and …
fiercebiotech.com
OFF
Atalanta Therapeutics Unveils $97M To Reach The Clinic In Two …
3 weeks from now
Jan 29, 2025 · The Boston-based startup also announced $97 million in financing to advance those programs to the clinic and support other CNS therapies in its pipeline. An RNA …
oodaloop.com
OFF
Atalanta Therapeutics Raises $97 Million To Advance RNAi Therapies …
3 weeks from now
Jan 30, 2025 · The U.S. biotech company Atalanta Therapeutics announced this week that it has raised $97 million in an oversubscribed Series B financing round led by the Swedish …
biopharma-reporter.com
OFF
Atalanta Therapeutics Closes Oversubscribed $97 Million Series B ...
3 weeks from now
BOSTON, January 28, 2025--Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the …
yahoo.com
OFF
Atalanta Biotech: $97 Million For Advances In Rare Neurosciences
3 weeks from now
Jan 29, 2025 · Atalanta Therapeutics recently announced a funding round of $97 million, co-led by EQT Life Sciences and Sanofi Ventures, to support the development of two therapeutic …
globalsante.org
OFF
RNAi Biotech Atalanta Unveils $97M To Reach The Clinic In Two …
3 weeks from now
Jan 29, 2025 · The other Atalanta program on track to the clinic is a potential treatment for a rare form of epilepsy driven by gain-of-function variants in the KCNT1 gene. Patients who have this …
newsguard.ca
OFF
Atalanta Gets $97 Million Series B To Target Neurological
3 weeks from now
Jan 28, 2025 · Atalanta Therapeutics, a Boston-based biotechnology company focused on neurological diseases, announced Monday the completion of a $97 million series B financing …
biospace.com
OFF
Atalanta Raises $97M To Advance Two Neuro-Targeting RNAi …
3 weeks from now
3 days ago · Atalanta Therapeutics has netted a $97 million Series B financing to support Phase I clinical trials of the company’s lead investigational RNAi therapies for KCNT1-related epilepsy …
insideprecisionmedicine.com
OFF
Boston Biotech News - Boston Business Journal
3 weeks from now
Boston biotech Atalanta raises $97M to bring CNS drugs into clinic Jan 28, 2025, 5:21 am EST Health Care Vertex is hoping for 'historic' non-opioid painkiller approval.
bizjournals.com
OFF
Vinsure - Boston Biotech Atalanta Raises $97M To Bring CNS Drugs …
3 weeks from now
Jan 28, 2025 · The Boston biotech is the latest to capitalize on the growing interest behind RNA interference (RNAi)-based medicines.. Highlights include Vinsure , Accident Health Insurance , …
vinsure.com
OFF
Atalanta Raises $97m To Advance RNAi Therapies For Epilepsy …
3 weeks from now
Feb 2, 2023 · The company believes its divalent small interfering RNA technology can boost CNS penetration and durability and aims to have its first two programs in the clinic by 2026. ...
citeline.com
OFF
Biotech Leaders Ask Equity Investors, Pharma To 'step Up' - Boston ...
3 weeks from now
1 day ago · Boston biotech raises $97M to bring CNS drugs into clinic Boston biotech raises $97M to bring CNS drugs into clinic. Lantheus is on a buying spree. Its latest deal is worth up to $1B
bizjournals.com
OFF
Atalanta Gets $97M Boost To Take Two SiRNAs Into Clinic For Rare …
3 weeks from now
Jan 28, 2025 · For five years, Atalanta Therapeutics operated with one investor. Now, F-Prime Capital is getting a bevy of financial support to propel two of the Boston biotech's RNAi drugs …
endpts.com
OFF
Edtech Startup Letterly Gets New Venture Capital Funding - Boston ...
3 weeks from now
8 hours ago · Epipelagic Ventures is focused on education and technology investments in the Boston area. ... raises $97M to bring CNS drugs into clinic Boston biotech raises $97M to …
bizjournals.com
FAQs about Boston biotech Atalanta raises $97M to bring CNS drugs into clinic Coupon?
Can Atalanta's di-siRNA technology cure neurological diseases?
Will NIH dollars replace federal funding for scientific research in Massachusetts?
Why did Atalanta invest in di-siRNA?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
